Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma

It is largely recognized that fibroblast activation protein (FAP) is expressed in cancer-associated fibroblasts (CAFs) of many human carcinomas. Furthermore, FAP was recently also reported to be expressed in carcinoma cells of the breast, stomach, pancreatic ductal adenocarcinoma, colorectum, and uterine cervix. The carcinoma cell expression pattern of FAP has been described in several types of cancers, but the role of FAP in oral squamous cell carcinoma (OSCC) is unknown. The role of endogenous FAP in epithelium-derived tumors and molecular mechanisms has also not been reported. In this study, FAP was found to be expressed in carcinoma cells of OSCC and was upregulated in OSCC tissue samples compared with benign tissue samples using immunohistochemistry. In addition, its expression level was closely correlated with overall survival of patients with OSCC. Silencing FAP inhibited the growth and metastasis of OSCC cells in vitro and in vivo. Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its downstream signaling regulating proliferation, migration, and invasion in OSCC cells, as the inhibitory effects of FAP on the proliferation and metastasis could be rescued by PTEN silencing. Our study suggests that FAP acts as an oncogene and may be a potential therapeutic target for patients with OSCC.

[1]  S. Korourian,et al.  Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[2]  Min Shi,et al.  Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. , 2012, World journal of gastroenterology.

[3]  E. Cukierman,et al.  FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells , 2011, BMC Cancer.

[4]  S. Bao,et al.  Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt‐mediated HIF‐1α up‐regulation and MMP9 activation , 2009, Journal of cellular and molecular medicine.

[5]  F. Marincola,et al.  Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma , 2013, Cell Death and Disease.

[6]  Ø. Bruserud,et al.  PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells , 2013, Cell Death and Disease.

[7]  R. Gilbert,et al.  Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma , 2010, Molecular Cancer.

[8]  J. Yun,et al.  KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a , 2013, Cell Death and Disease.

[9]  L. Weiner,et al.  Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma , 2008, Pancreas.

[10]  S. Staibano,et al.  FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential , 2013, Cell Death and Disease.

[11]  T. Han,et al.  Cyclin G1–mediated epithelial‐mesenchymal transition via phosphoinositide 3‐kinase/Akt signaling facilitates liver cancer progression , 2012, Hepatology.

[12]  P. Cohen,et al.  The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.

[13]  K. Okada,et al.  Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. , 2003, Cancer letters.

[14]  Huiling Yang,et al.  Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma , 2011, PloS one.

[15]  H. Fujii,et al.  The Expression of a Type II Transmembrane Serine Protease (Seprase) in Human Gastric Carcinoma , 2005, Oncology.

[16]  K. Okada,et al.  Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm. , 2003, Anticancer research.

[17]  Xinke Zhou,et al.  Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition , 2013, Journal of cellular and molecular medicine.

[18]  Dan Sun,et al.  Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1 , 2010, Journal of cellular and molecular medicine.

[19]  D. Radisky,et al.  Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression? , 2008, Nature Clinical Practice Oncology.

[20]  P. Doevendans,et al.  MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16 , 2012, Journal of cellular and molecular medicine.

[21]  Shelly R. Peyton,et al.  The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function , 2007, Cell Biochemistry and Biophysics.

[22]  N. D’Silva,et al.  Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6 , 2013, Clinical Cancer Research.

[23]  Li-Na Yu,et al.  Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma , 2011, Diagnostic pathology.

[24]  Hung-Ming Wang,et al.  Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing–prevalent area , 2011, Head & neck.

[25]  Gema Moreno-Bueno,et al.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.

[26]  Hongyu Liu,et al.  Fibroblast activation protein-α promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms. , 2013, Experimental and molecular pathology.

[27]  Liang Han,et al.  Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells. , 2013, Current medicinal chemistry.

[28]  V. Sukhatme,et al.  ATP citrate lyase knockdown impacts cancer stem cells in vitro , 2013, Cell Death and Disease.

[29]  Guojun Li,et al.  Expression of Angiopoietin-2 and Vascular Endothelial Growth Factor Receptor-3 Correlates with Lymphangiogenesis and Angiogenesis and Affects Survival of Oral Squamous Cell Carcinoma , 2013, PloS one.

[30]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[31]  R. Mehrotra,et al.  Identification of high-risk human papillomavirus-16 and-18 infections by multiplex PCR and their expression in oral submucous fibrosis and oral squamous cell carcinoma , 2013 .

[32]  A. Markopoulos.  Current Aspects on Oral Squamous Cell Carcinoma , 2012, The open dentistry journal.

[33]  R. Palmqvist,et al.  High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis , 2013, Tumor Biology.

[34]  A. Rangarajan,et al.  Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters , 2011, Cell Death and Disease.

[35]  S. Barsky,et al.  ERα signaling through slug regulates E-cadherin and EMT , 2010, Oncogene.

[36]  Lu Dong-dong,et al.  Expression and significance of new tumor suppressor gene PTEN in primary liver cancer , 2003, Journal of cellular and molecular medicine.

[37]  Y. Ni,et al.  Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis , 2013, Journal of Cancer Research and Clinical Oncology.

[38]  T. Yen,et al.  Gα12 Drives Invasion of Oral Squamous Cell Carcinoma through Up-Regulation of Proinflammatory Cytokines , 2013, PloS one.

[39]  J. López‐López,et al.  Oral tongue squamous cell carcinoma (OTSCC): alcohol and tobacco consumption versus non-consumption. A study in a Portuguese population. , 2011, Brazilian dental journal.